Insulin-like growth factor binding protein 7 exhibits tumor suppressive and vessel stabilization properties in U87MG and T98G glioblastoma cell lines

Cancer Biology and Therapy

Volumn 12, Issue 7, 2011, Pages 634-646

  Pen, Ally ^a,b   Durocher, Yves ^a   Slinn, Jacqueline ^a   Rukhlova, Marina ^a   Charlebois, Claudie ^a   Stanimirovic, Danica B ^a,b   Moreno, Maria J ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Angiogenesis; Glioblastoma; IGFBP7; Pericyte recruitment; Tumor suppressor

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN PHOSPHORYLATION; SENESCENCE; SMOOTH MUSCLE FIBER;

ANIMALS; ANNEXIN A5; AORTA; APOPTOSIS; BETA-GALACTOSIDASE; CELL AGING; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIUM, VASCULAR; GLIOBLASTOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION;

EID: 80053399155     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.7.17171     Document Type: Article

References (65)

1. Vajkoczy P, Menger MD. Vascular microenvironment in gliomas. J Neurooncol 2000; 50:99-108; PMID:11245285; DOI:10.1023/A:1006474832189.
2. Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol 2006; 1:97-117; PMID:18039109; DOI:10.1146/annurev.pathol.1.110304.100043.
3. Bansal K, Liang ML, Rutka JT. Molecular biology of human gliomas. Technol Cancer Res Treat 2006; 5:185-94; PMID:16700615.
4. Trojan J, Cloix JF, Ardourel MY, Chatel M, Anthony DD. Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience 2007; 145:795-811; PMID:17320297; DOI:10.1016/j.neuroscience. 2007.01.021.
5. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20:761-87; PMID:10605625; DOI:10.1210/er.20.6.761.
6. Burger AM, Spyropoulos DD, Kahn HJ, Seth AK. Development of an insulin-like growth factor binding protein-related protein 1 knockout mouse. Proc Am Assoc Cancer Res 2005; 46:1080.
7. Swisshelm K, Ryan K, Tsuchiya K, Sager R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 1995; 92:4472-6; PMID:7538673; DOI:10.1073/pnas.92.10.4472.
8. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996; 271:30322-5; PMID:8939990; DOI:10.1074/jbc.271.48.30322.
9. Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK. Essential roles of IGFBP-3 and IGFBPrP1 in breast cancer. Eur J Cancer 2005; 41:1515-27; PMID:15979304; DOI:10.1016/j.ejca.2005.04.023.
10. Oh Y. IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 1998; 47:283-93; PMID:9516082; DOI:10.1023/A:1005911319432.
11. Umeda F, Ono Y, Sekiguchi N, Hashimoto T, Masakado M, Nakamura K, et al. Increased mRNA expression of a novel prostacyclin-stimulating factor in human colon cancer. J Gastroenterol 1998; 33:213-7; PMID:9605951; DOI:10.1007/ s005350050072.
12. How HK, Yeoh A, Quah TC, Oh Y, Rosenfeld RG, Lee KO. Insulin-like growth factor binding proteins (IGFBPs) and IGFBP-related protein 1-levels in cerebrospinal fluid of children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1999; 84:1283-7; PMID:10199768; DOI:10.1210/jc.84.4.1283.
13. Akaogi K, Okabe Y, Sato J, Nagashima Y, Yasumitsu H, Sugahara K, et al. Specific accumulation of tumorderived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci USA 1996; 93:8384-9; PMID:8710880; DOI:10.1073/pnas.93.16.8384.
14. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, et al. Genes expressed in human tumor endothelium. Science 2000; 289:1197-202; PMID:10947988; DOI:10.1126/science. 289.5482.1197.
15. Pen A, Moreno MJ, Martin J, Stanimirovic DB. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of lasercaptured glioblastoma vessels. Glia 2007; 55:559-72; PMID:17266141; DOI:10.1002/glia.20481.
16. Pen A, Moreno MJ, Durocher Y, Deb-Rinker P, Stanimirovic DB. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGFbeta signaling. Oncogene 2008; 27:6834-44; PMID:18711401; DOI:10.1038/ onc.2008.287.
17. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8:21-43; PMID:9174661; DOI:10.1016/S1359-6101(96)00048-2.
18. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003; 9:685-93; PMID:12778167; DOI:10.1038/nm0603-685.
19. Hwa V, Tomasini-Sprenger C, Bermejo AL, Rosenfeld RG, Plymate SR. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells. J Clin Endocrinol Metab 1998; 83:4355- 62; PMID:9851777; DOI:10.1210/jc.83.12.4355.
20. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR. Insulin-like growth factor binding protein- related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res 1999; 59:2370-5; PMID:10344746.
21. Landberg G, Ostlund H, Nielsen NH, Roos G, Emdin S, Burger AM, et al. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene 2001; 20:3497-505; PMID:11429696; DOI:10.1038/ sj.onc.1204471.
22. Komatsu S, Okazaki Y, Tateno M, Kawai J, Konno H, Kusakabe M, et al. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem Biophys Res Commun 2000; 267:109-17; PMID:10623583; DOI:10.1006/ bbrc.1999.1937.
23. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993; 4:715-22; PMID:7694637.
24. Kato MV, Sato H, Tsukada T, Ikawa Y, Aizawa S, Nagayoshi M. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells. Oncogene 1996; 12:1361-4; PMID:8649839.
25. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, et al. Downregulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998; 16:2459-67; PMID:9627112; DOI:10.1038/sj.onc.1201772.
26. Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein- related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 2002; 13:205-13; PMID:12065244.
27. Mutaguchi K, Yasumoto H, Mita K, Matsubara A, Shiina H, Igawa M, et al. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res 2003; 63:7717-23; PMID:14633696.
28. Sprenger CC, Vail ME, Evans K, Simurdak J, Plymate SR. Overexpression of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Oncogene 2002; 21:140-7; PMID:11791184; DOI:10.1038/sj.onc.1205021.
29. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132:363-74; PMID:18267069; DOI:10.1016/j.cell.2007. 12.032.
30. Chen Y, Pacyna-Gengelbach M, Ye F, Knosel T, Lund P, Deutschmann N, et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. J Pathol 2007; 211:431-8; PMID:17236181; DOI:10.1002/path.2132.
31. Lin J, Lai M, Huang Q, Ma Y, Cui J, Ruan W. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression. J Pathol 2007; 212:83-90; PMID:17334979; DOI:10.1002/path.2144.
32. Chiarugi P, Fiaschi T. Redox signalling in anchorage- dependent cell growth. Cell Signal 2007; 19:672-82; PMID:17204396; DOI:10.1016/j.cellsig. 2006.11.009.
33. Moreno MJ, Ball M, Andrade MF, McDermid A, Stanimirovic DB. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)- differentiated glioblastoma cells. Glia 2006; 53:845-57; PMID:16586492; DOI:10.1002/glia.20345.
34. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and antiangiogenesis in vivo. Anat Rec 2001; 264:317-24; PMID:11745087; DOI:10.1002/ar.10021.
35. Knighton D, Ausprunk D, Tapper D, Folkman J. Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 1977; 35:347-56; PMID:856240; DOI:10.1038/bjc.1977.49.
36. Pfeifer A, Kessler T, Silletti S, Cheresh DA, Verma IM. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc Natl Acad Sci USA 2000; 97:12227-32; PMID:11035804; DOI:10.1073/pnas.220399597.
37. van der Schaft DW, Dings RP, De Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, et al. The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. FASEB J 2002; 16:1991-3; PMID:12397082.
38. Hagedorn M, Javerzat S, Gilges D, Meyre A, De Lafarge B, Eichmann A, et al. Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci USA 2005; 102:1643-8; PMID:15665100; DOI:10.1073/pnas.0408622102.
39. Armulik A, Abramsson A, Betsholtz C. Endothelial/ pericyte interactions. Circ Res 2005; 97:512- 23; PMID:16166562; DOI:10.1161/01.RES.0000182903.16652. d7.
40. Grotendorst GR, Chang T, Seppa HE, Kleinman HK, Martin GR. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol 1982; 113:261-6; PMID:6184376; DOI:10.1002/jcp.1041130213.
41. Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q, et al. IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biol Ther 2007; 6:354-9; PMID:17312390; DOI:10.4161/ cbt.6.3.3702.
42. Sato Y, Chen Z, Miyazaki K. Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25. Cancer Sci 2007; 98:1055- 63; PMID:17465992; DOI:10.1111/j.1349- 7006.2007.00502.x.
43. Degeorges A, Wang F, Frierson HF Jr, Seth A, Sikes RA. Distribution of IGFBP-rP1 in normal human tissues. J Histochem Cytochem 2000; 48:747-54; PMID:10820148; DOI:10.1177/002215540004800603.
44. Zumkeller W, Muller D, Muller S, Gunther C, Westphal M. Expression and synthesis of insulin-like growth factor-binding proteins in human glioma cell lines. Int J Oncol 1998; 12:129-35; PMID:9454896.
45. Danen EH, Yamada KM. Fibronectin, integrins and growth control. J Cell Physiol 2001; 189:1-13; PMID:11573199; DOI:10.1002/jcp.1137.
46. Jiang W, Xiang C, Cazacu S, Brodie C, Mikkelsen T. Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration. Neoplasia (New York, NY) 2008; 10:1335-42.
47. Drivdahl R, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, Plymate SR. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 2004; 23:4584-93; PMID:15077158; DOI:10.1038/sj.onc.1207603.
48. Wajapeyee N, Kapoor V, Mahalingam M, Green MR. Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines. Mol Cancer Ther 2009; 8:3009-14; PMID:19861408; DOI:10.1158/1535- 7163.MCT- 09-0470.
49. Brat DJ, van Meir EG. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am J Pathol 2001; 158:789-96; PMID:11238026; DOI:10.1016/S0002- 9440(10)64025-4.
50. Vontell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006; 312:623-9; PMID:16303125; DOI:10.1016/j.yexcr.2005.10.019.
51. Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, et al. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. Eur J Cancer 2006; 42:310-8; PMID:16406506; DOI:10.1016/j.ejca.2005.11.010.
52. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGFbeta and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141:805-14; PMID:9566978; DOI:10.1083/jcb.141.3.805.
53. Paik JH, Skoura A, Chae SS, Cowan AE, Han DK, Proia RL, et al. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev 2004; 18:2392-403; PMID:15371328; DOI:10.1101/gad. 1227804.
54. Nishishita T, Lin PC. Angiopoietin 1, PDGF-B and TGFbeta gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 2004; 91:584- 93; PMID:14755687; DOI:10.1002/jcb.10718.
55. Liu LX, Huang S, Zhang QQ, Liu Y, Zhang DM, Guo XH, et al. Insulin-like growth factor binding protein-7 induces activation and transdifferentiation of hepatic stellate cells in vitro. World J Gastroenterol 2009; 15:3246-53; PMID:19598300; DOI:10.3748/ wjg.15.3246.
56. Ronnov-Jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol 1996; 134:67-80; PMID:8698823; DOI:10.1083/jcb.134.1.67.
57. Bergers G, Song S. The role of pericytes in bloodvessel formation and maintenance. Neuro-oncol 2005; 7:452-64; PMID:16212810; DOI:10.1215/ S1152851705000232.
58. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 2004; 64:3731-6; PMID:15172975; DOI:10.1158/0008-5472.CAN- 04-0074.
59. Ergün S, Kilic N, Wurmbach JH, Ebrahimnejad A, Fernando M, Sevinc S, et al. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis 2001; 4:193-206; PMID:11911017; DOI:10.1023/A:1014027218980.
60. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307:58-62; PMID:15637262; DOI:10.1126/ science.1104819.
61. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 2007; 74:72-84; PMID:17560615; DOI:10.1016/j.mvr.2007.05.003.
62. Moreno MJ, Cohen Z, Stanimirovic DB, Hamel E. Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels and cerebromicrovascular or astroglial cells in culture. J Cereb Blood Flow Metab 1999; 19:1270- 8; PMID:10566974; DOI:10.1097/00004647- 199911000-00012.
63. Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 2002; 30:9; PMID:11788735; DOI:10.1093/nar/30.2.e9.
64. Tom R, Bisson L, Durocher Y. Transfection of HEK293-EBNA1 Cells in suspension with linear pei for production of recombinant proteins. Cold Spring Harbor Protocols 2008; 4:4977.
65. Tom R, Bisson L, Durocher Y. Purification of histagged proteins using fractogel-cobalt. Cold Spring Harbor Protocols 2008; 4:4980.